The results showed that there were 14 traditional Chinese medicines targeting PCa with PRDX4, among which 5 had statistical differences, including Shi Liu Zi, Yuan Can E, Can Sha, Shi Liu Hua, and Shi Liu Pi (all P<0.05). Here, PRDX4 is linked to posterior cortical atrophy.